PT2959903T - Medicamento para tratar doença ocular - Google Patents
Medicamento para tratar doença ocularInfo
- Publication number
- PT2959903T PT2959903T PT14754749T PT14754749T PT2959903T PT 2959903 T PT2959903 T PT 2959903T PT 14754749 T PT14754749 T PT 14754749T PT 14754749 T PT14754749 T PT 14754749T PT 2959903 T PT2959903 T PT 2959903T
- Authority
- PT
- Portugal
- Prior art keywords
- medicine
- eye disease
- treating eye
- treating
- disease
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000030533 eye disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013031190 | 2013-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2959903T true PT2959903T (pt) | 2019-01-17 |
Family
ID=51391281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT14754749T PT2959903T (pt) | 2013-02-20 | 2014-02-19 | Medicamento para tratar doença ocular |
Country Status (8)
Country | Link |
---|---|
US (1) | US9782420B2 (pt) |
EP (1) | EP2959903B1 (pt) |
JP (1) | JP6261011B2 (pt) |
DK (1) | DK2959903T3 (pt) |
ES (1) | ES2691805T3 (pt) |
PL (1) | PL2959903T3 (pt) |
PT (1) | PT2959903T (pt) |
WO (1) | WO2014129495A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9931351B2 (en) | 2013-09-04 | 2018-04-03 | Kyoto University | Method for improving leptin resistance |
JPWO2017222042A1 (ja) * | 2016-06-24 | 2019-04-11 | 国立大学法人京都大学 | 眼用医薬組成物 |
JP6308285B1 (ja) * | 2016-12-08 | 2018-04-11 | コニカミノルタ株式会社 | 透明基板積層体の製造方法および空中映像表示デバイスの製造方法 |
EP3733177B1 (en) * | 2017-12-27 | 2022-07-06 | Kyoto University | Composition for protecting cornea |
WO2019203176A1 (ja) | 2018-04-16 | 2019-10-24 | 国立大学法人京都大学 | 心筋細胞の保護用の医薬組成物 |
JP7101982B2 (ja) | 2018-07-31 | 2022-07-19 | 国立大学法人京都大学 | 脳梗塞の処置用の医薬組成物 |
CN114599370A (zh) | 2019-10-24 | 2022-06-07 | 国立大学法人京都大学 | 用于保护软骨的药物组合物 |
JP7705649B2 (ja) | 2021-04-28 | 2025-07-10 | 国立大学法人京都大学 | 皮膚組織の異常を改善するための組成物 |
US20250057823A1 (en) | 2021-12-24 | 2025-02-20 | Kyoto University | Composition for improving cardiac function |
WO2024090512A1 (ja) * | 2022-10-27 | 2024-05-02 | 株式会社京都創薬研究所 | ナフタレン誘導体の結晶 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ286632B6 (cs) | 1992-09-29 | 2000-05-17 | Inhale Therapeutic Systems | Farmaceutický prostředek |
US20030065020A1 (en) * | 2001-07-13 | 2003-04-03 | Catharine Gale | Treatment of macular degeneration |
US8457178B2 (en) | 2007-03-26 | 2013-06-04 | Qualcomm Incorporated | Frequency offset estimator |
PT2599771T (pt) * | 2010-07-30 | 2016-12-14 | Univ Kyoto | Derivado de naftaleno |
ES2574832T3 (es) | 2010-09-30 | 2016-06-22 | Kyoto University | Agente para el tratamiento de enfermedades oculares |
-
2014
- 2014-02-19 PL PL14754749T patent/PL2959903T3/pl unknown
- 2014-02-19 EP EP14754749.1A patent/EP2959903B1/en active Active
- 2014-02-19 US US14/768,949 patent/US9782420B2/en active Active
- 2014-02-19 ES ES14754749.1T patent/ES2691805T3/es active Active
- 2014-02-19 WO PCT/JP2014/053898 patent/WO2014129495A1/ja active Application Filing
- 2014-02-19 PT PT14754749T patent/PT2959903T/pt unknown
- 2014-02-19 DK DK14754749.1T patent/DK2959903T3/en active
- 2014-02-19 JP JP2015501476A patent/JP6261011B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP2959903B1 (en) | 2018-10-03 |
DK2959903T3 (en) | 2019-01-21 |
EP2959903A4 (en) | 2016-08-03 |
EP2959903A1 (en) | 2015-12-30 |
PL2959903T3 (pl) | 2019-03-29 |
US20160000810A1 (en) | 2016-01-07 |
JPWO2014129495A1 (ja) | 2017-02-02 |
JP6261011B2 (ja) | 2018-01-17 |
US9782420B2 (en) | 2017-10-10 |
WO2014129495A1 (ja) | 2014-08-28 |
ES2691805T3 (es) | 2018-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268987B (en) | Glaucoma treatment system | |
IL278018A (en) | Methods for the treatment or prevention of ophthalmological conditions | |
IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
PL2764881T3 (pl) | System leczenia medycznego | |
PL2959903T3 (pl) | Lek do leczenia chorób oczu | |
PL3073936T3 (pl) | Wszczep medyczny | |
HUE046702T2 (hu) | Eljárások üvegcsontbetegség kezelésére | |
PL3730035T3 (pl) | Urządzenie okulistyczne | |
EP2952149A4 (en) | THERAPEUTIC TREATMENT DEVICE | |
GB201308131D0 (en) | Ophthalmoscope | |
IL246541A0 (en) | From a versatile light-guided eyepiece treatment system | |
SG11201601436YA (en) | Ophthalmic solution | |
GB201314386D0 (en) | Treatment system for aquaculture | |
GB201304872D0 (en) | Treatment | |
GB201313704D0 (en) | Engineered neural tissue | |
GB201308440D0 (en) | Therapeutic | |
EP3080602A4 (en) | Treating neurodegenerative disease | |
EP2968452A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF NETWORK DISEASES | |
SI3041575T1 (sl) | Medicinska naprava | |
GB201313356D0 (en) | Therapeutic Intervention | |
GB201318668D0 (en) | Sonosensitive therapeutic | |
GB201307348D0 (en) | Garment for therapeutic treatment | |
GB201307310D0 (en) | Treatment | |
GB201321628D0 (en) | Treatment of disease | |
GB201406225D0 (en) | Treatment for respiratory disease |